Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms

Jenny Rinke(Jena University Hospital), Thomas Ernst(Jena University Hospital)
Leukemia
June 19, 2017
10.1038/leu.2017.190
Cited by 32

Related Papers

PD-1 Blockade in Anaplastic Thyroid Carcinoma
|Journal of Clinical Oncology|2020|349
ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia
|Haematologica|2008|50
SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders
|Leukemia|2020|49